Literature DB >> 7698120

Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.

S E Hoffner1.   

Abstract

Pulmonary mycobacteriosis is usually caused by Mycobacterium tuberculosis or Mycobacterium avium complex. There are, however, other slow-growing mycobacteria that can cause pulmonary infection. Mycobacterium kansasii, Mycobacterium malmoense, Mycobacterium xenopi, Mycobacterium szulgai and Mycobacterium simiae typically infect middle-aged to elderly persons with preexisting lung disease. Differentiation of infection with these five mycobacteria from infection with Mycobacterium tuberculosis, by culture and determination of the antimicrobial susceptibility pattern of the organism are important for several reasons. All five organisms are found in water and soil. They probably infect humans from environmental habitats; human-to-human spread of infection is thought not to occur. Furthermore, isolation of the organisms in culture may represent contamination of the specimen or colonization of the patient, and not necessarily an infection. Finally, although the antituberculosis drugs-isoniazid, ethambutol, rifampin and streptomycin-have been used for treatment of infection with these five organisms, there are often differences between the antimycobacterial susceptibility patterns of Mycobacterium tuberculosis and those of the non-tuberculous mycobacteria. Thus, the optimal choice of drug therapy may differ from that used for tuberculosis.

Entities:  

Mesh:

Year:  1994        PMID: 7698120     DOI: 10.1007/bf02111495

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

1.  A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man.

Authors:  H SCHWABACHER
Journal:  J Hyg (Lond)       Date:  1959-03

2.  Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.

Authors:  U Hjelm; J Kaustová; M Kubín; S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

3.  Mycobacterium kansasii from an environmental source.

Authors:  A C Maniar; L R Vanbuckenhout
Journal:  Can J Public Health       Date:  1976 Jan-Feb

4.  Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory.

Authors:  P Kirschner; B Springer; U Vogel; A Meier; A Wrede; M Kiekenbeck; F C Bange; E C Böttger
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

5.  Pulmonary infection with nontuberculous mycobacteria.

Authors:  M A Contreras; O T Cheung; D E Sanders; R S Goldstein
Journal:  Am Rev Respir Dis       Date:  1988-01

6.  Isolation of mycobacteria from healthy persons' stools.

Authors:  F Portaels; L Larsson; P Smeets
Journal:  Int J Lepr Other Mycobact Dis       Date:  1988-09

7.  Isolation of nontuberculous mycobacteria in the United States, 1980.

Authors:  R C Good; D E Snider
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

8.  Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin.

Authors:  W Pezzia; J W Raleigh; M C Bailey; E A Toth; J Silverblatt
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

9.  Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.

Authors:  J Banks; P A Jenkins; A P Smith
Journal:  Tubercle       Date:  1985-09

10.  Mycobacterium kansasii infection in an endemic area of Czechoslovakia.

Authors:  M Kubín; E Svandová; B Medek; S Chobot; Z Olsovský
Journal:  Tubercle       Date:  1980-12
View more
  10 in total

1.  Conventional methods versus 16S ribosomal DNA sequencing for identification of nontuberculous mycobacteria: cost analysis.

Authors:  Victoria J Cook; Christine Y Turenne; Joyce Wolfe; Ryan Pauls; Amin Kabani
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 2.  Treatment of spondylodiscitis.

Authors:  Kourosh Zarghooni; Marc Röllinghoff; Rolf Sobottke; Peer Eysel
Journal:  Int Orthop       Date:  2011-12-06       Impact factor: 3.075

3.  Are cultures needed to enroll tuberculosis patients?

Authors:  Mihai-Sergiu Jalba
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

4.  The Use of High Performance Liquid Chromatography to Speciate and Characterize the Epidemiology of Mycobacteria.

Authors:  Joseph Jeong; Sung-Ryul Kim; Seon Ho Lee; Ji-Hun Lim; Jung In Choi; Jae Sun Park; Chulhun L Chang; Jun Yong Choi; Douglas D Richman; Davey M Smith
Journal:  Lab Med       Date:  2011-10-01

5.  Mycobacterium heckeshornense sp. nov., A new pathogenic slowly growing Mycobacterium sp. Causing cavitary lung disease in an immunocompetent patient.

Authors:  A Roth; U Reischl; N Schönfeld; L Naumann; S Emler; M Fischer; H Mauch; R Loddenkemper; R M Kroppenstedt
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media.

Authors:  M Sanguinetti; B Posteraro; F Ardito; S Zanetti; A Cingolani; L Sechi; A De Luca; L Ortona; G Fadda
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 7.  Mycobacterial taxonomy.

Authors:  T M Shinnick; R C Good
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

8.  PCR assay based on DNA coding for 16S rRNA for detection and identification of mycobacteria in clinical samples.

Authors:  L F Kox; J van Leeuwen; S Knijper; H M Jansen; A H Kolk
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Mycobacterium xenopi: Evidence for Increased Rate of Clinical Isolation.

Authors:  Martin H Bluth; Ramon Vera; Jafar Razeq; Martin Kramer; Khaled I Abu-Lawi
Journal:  Int J Biomed Sci       Date:  2009-06

10.  Rapid identification of mycobacteria from positive MGIT broths of primary cultures by MALDI-TOF mass spectrometry.

Authors:  Tsi-Shu Huang; Chia-Chien Lee; Hui-Zin Tu; Susan Shin-Jung Lee
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.